USTEKINUMAB-STBA

371 reported adverse events

Drug classes: Interleukin-12 Antagonist [EPC] Interleukin-23 Antagonist [EPC]

USTEKINUMAB-STBA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VIRAL EPIGLOTTITIS 1 0.3333
1 HARVEY-BRADSHAW INDEX DECREASED 1 0.1667
2 FAILED BACK SURGERY SYNDROME 1 0.0455
3 ULCERATIVE DUODENITIS 1 0.0244
4 BOWEL OBSTRUCTION SURGERY 1 0.0182
5 UROSTOMY 2 0.0168
6 UNADJUSTED DOSE ADMINISTERED 1 0.0147
7 SUSPECTED OFF LABEL USE 45 0.0100
8 SEXUAL ACTIVITY INCREASED 1 0.0084
9 SALIVARY DUCT OBSTRUCTION 1 0.0072
See all enriched reactions for USTEKINUMAB-STBA